287 related articles for article (PubMed ID: 23840758)
1. The overexpression of Twinkle helicase ameliorates the progression of cardiac fibrosis and heart failure in pressure overload model in mice.
Tanaka A; Ide T; Fujino T; Onitsuka K; Ikeda M; Takehara T; Hata Y; Ylikallio E; Tyynismaa H; Suomalainen A; Sunagawa K
PLoS One; 2013; 8(6):e67642. PubMed ID: 23840758
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of TFAM or twinkle increases mtDNA copy number and facilitates cardioprotection associated with limited mitochondrial oxidative stress.
Ikeda M; Ide T; Fujino T; Arai S; Saku K; Kakino T; Tyynismaa H; Yamasaki T; Yamada K; Kang D; Suomalainen A; Sunagawa K
PLoS One; 2015; 10(3):e0119687. PubMed ID: 25822152
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction.
Ikeuchi M; Matsusaka H; Kang D; Matsushima S; Ide T; Kubota T; Fujiwara T; Hamasaki N; Takeshita A; Sunagawa K; Tsutsui H
Circulation; 2005 Aug; 112(5):683-90. PubMed ID: 16043643
[TBL] [Abstract][Full Text] [Related]
4. Twinkle overexpression prevents cardiac rupture after myocardial infarction by alleviating impaired mitochondrial biogenesis.
Inoue T; Ikeda M; Ide T; Fujino T; Matsuo Y; Arai S; Saku K; Sunagawa K
Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H509-19. PubMed ID: 27342873
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of mitochondrial creatine kinase preserves cardiac energetics without ameliorating murine chronic heart failure.
Cao F; Maguire ML; McAndrew DJ; Lake HA; Neubauer S; Zervou S; Schneider JE; Lygate CA
Basic Res Cardiol; 2020 Jan; 115(2):12. PubMed ID: 31925563
[TBL] [Abstract][Full Text] [Related]
6. Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction.
Du XJ; Fang L; Gao XM; Kiriazis H; Feng X; Hotchkin E; Finch AM; Chaulet H; Graham RM
J Mol Cell Cardiol; 2004 Nov; 37(5):979-87. PubMed ID: 15522275
[TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling.
Nagai T; Anzai T; Mano Y; Kaneko H; Anzai A; Sugano Y; Maekawa Y; Takahashi T; Yoshikawa T; Fukuda K
Heart Vessels; 2013 May; 28(3):404-11. PubMed ID: 22875408
[TBL] [Abstract][Full Text] [Related]
8. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload.
Grote-Wessels S; Baba HA; Boknik P; El-Armouche A; Fabritz L; Gillmann HJ; Kucerova D; Matus M; Müller FU; Neumann J; Schmitz M; Stümpel F; Theilmeier G; Wohlschlaeger J; Schmitz W; Kirchhefer U
Cardiovasc Res; 2008 Aug; 79(3):464-71. PubMed ID: 18453636
[TBL] [Abstract][Full Text] [Related]
10. Dapagliflozin Attenuates Cardiac Remodeling in Mice Model of Cardiac Pressure Overload.
Shi L; Zhu D; Wang S; Jiang A; Li F
Am J Hypertens; 2019 Apr; 32(5):452-459. PubMed ID: 30689697
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
Besnier M; Coquerel D; Favre J; Dumesnil A; Guerrot D; Remy-Jouet I; Mulder P; Djerada Z; Tamion F; Richard V; Ouvrard-Pascaud A
Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1279-H1288. PubMed ID: 29569957
[TBL] [Abstract][Full Text] [Related]
14. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency.
Ichinose F; Bloch KD; Wu JC; Hataishi R; Aretz HT; Picard MH; Scherrer-Crosbie M
Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H1070-5. PubMed ID: 14644766
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response.
Nagai T; Anzai T; Kaneko H; Mano Y; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
Hypertension; 2011 Feb; 57(2):208-15. PubMed ID: 21220701
[TBL] [Abstract][Full Text] [Related]
16. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
[TBL] [Abstract][Full Text] [Related]
17. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
[TBL] [Abstract][Full Text] [Related]
19. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
Yu L; Ruifrok WP; Meissner M; Bos EM; van Goor H; Sanjabi B; van der Harst P; Pitt B; Goldstein IJ; Koerts JA; van Veldhuisen DJ; Bank RA; van Gilst WH; Silljé HH; de Boer RA
Circ Heart Fail; 2013 Jan; 6(1):107-17. PubMed ID: 23230309
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
